Clinical Research Directory
Browse clinical research sites, groups, and studies.
International Multicentric Study ARON-1
Sponsor: Hospital of Macerata
Summary
The ARON-1 Study is designed as an International Multicentric Retrospective Study to collect global experiences with the use of immuno-combinations in patients with metastatic RCC. Two Supplementary Studies (ARON-1α and ARON-1β) have been designed. The ARON-1α Supplementary Study has been designed to investigate for the presence of genomic signatures from tumor samples of patients treated with first-line immuno-combinations for advanced RCC. The ARON-1β Supplementary Study has been designed to charaterize the immune cell populations and assess their relationship with the clinical outcome of mRCC patients treated with first-line immuno-combinations
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1220
Start Date
2022-03-10
Completion Date
2027-09-30
Last Updated
2025-11-26
Healthy Volunteers
No
Conditions
Interventions
pembrolizumab plus axitinib
collect global experiences with the use of immuno-combinations in patients with metastatic RCC
Locations (1)
Ospedale di Macerata, UOC Oncologia
Macerata, Macerata, Italy